Additionally, HBV stimulates Kiaa1429-mediated m6A modification to upregulate Ccr9, which stabilizes drug transporters ATP-binding cassette subfamily B member 1 (Abcb1) and subfamily C member 1 (Abcc1) expression, fostering HCC chemoresistance and poor prognosis111. Here, VIRMA is linked to hepatocellular carcinoma.